GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SynCore Biotechnology Co Ltd (ROCO:4192) » Definitions » Market Cap

SynCore Biotechnology Co (ROCO:4192) Market Cap : NT$1,610.56 Mil (As of May. 11, 2024)


View and export this data going back to 2014. Start your Free Trial

What is SynCore Biotechnology Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). SynCore Biotechnology Co's share price for the quarter that ended in Dec. 2023 was NT$38.4. SynCore Biotechnology Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 35.17 Mil. Therefore, SynCore Biotechnology Co's market cap for the quarter that ended in Dec. 2023 was NT$1,350.34 Mil.

SynCore Biotechnology Co's quarterly market cap declined from Jun. 2023 (NT$2,048.37 Mil) to Sep. 2023 (NT$1,383.52 Mil) and declined from Sep. 2023 (NT$1,383.52 Mil) to Dec. 2023 (NT$1,350.34 Mil).

SynCore Biotechnology Co's annual market cap declined from Dec. 2021 (NT$3,653.70 Mil) to Dec. 2022 (NT$2,922.95 Mil) and declined from Dec. 2022 (NT$2,922.95 Mil) to Dec. 2023 (NT$1,350.34 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. SynCore Biotechnology Co's Enterprise Value for Today is NT$1,341.32 Mil.


SynCore Biotechnology Co Market Cap Historical Data

The historical data trend for SynCore Biotechnology Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynCore Biotechnology Co Market Cap Chart

SynCore Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,921.02 4,977.15 3,653.70 2,922.95 1,350.34

SynCore Biotechnology Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,922.95 2,272.77 2,048.37 1,383.52 1,350.34

Competitive Comparison of SynCore Biotechnology Co's Market Cap

For the Biotechnology subindustry, SynCore Biotechnology Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SynCore Biotechnology Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SynCore Biotechnology Co's Market Cap distribution charts can be found below:

* The bar in red indicates where SynCore Biotechnology Co's Market Cap falls into.



SynCore Biotechnology Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

SynCore Biotechnology Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=NT$38.4*35.165
=NT$1,350.34

SynCore Biotechnology Co's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=NT$38.4*35.165
=NT$1,350.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SynCore Biotechnology Co  (ROCO:4192) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


SynCore Biotechnology Co Market Cap Related Terms

Thank you for viewing the detailed overview of SynCore Biotechnology Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


SynCore Biotechnology Co (ROCO:4192) Business Description

Traded in Other Exchanges
N/A
Address
No.84 Zhongshan Road, Zhongshan Village, Dongshan Township, Yilan, TWN, 269
SynCore Biotechnology Co Ltd is a biopharmaceutical company. Its pipeline products concentrate on the ophthalmology, oncology, and dermatology fields. The pipeline products of the company include SB01 and 02, SB03, SB04, and SB05. It is engaged in drug development and sale, food advisory, medicine inspection, biotechnology service and intellectual property. It operates in a single industry, the new drug development.

SynCore Biotechnology Co (ROCO:4192) Headlines

No Headlines